Risk Prediction With Procalcitonin and Clinical Rules in Community-Acquired Pneumonia

Annals of Emergency Medicine

Volumn 52, Issue 1, 2008, Pages

  Huang, David T ^a   Weissfeld, Lisa A ^a,b   Kellum, John A ^a   Yealy, Donald M ^a   Kong, Lan ^a,b   Martino, Michael ^c   Angus, Derek C ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c Jefferson Regional Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROCALCITONIN;

AGED; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; EMERGENCY WARD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PNEUMONIA SEVERITY INDEX; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RADIODIAGNOSIS; RATING SCALE; RISK; SENSITIVITY AND SPECIFICITY;

EID: 44949176523     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2008.01.003     Document Type: Article

References (44)

1. DeFrances C.J., and Podgornik M.N. 2004 National Hospital Discharge Survey. Adv Data 371 (2006) 1-19
2. Niederman M.S., McCombs J.S., Unger A.N., et al. The cost of treating community-acquired pneumonia. Clin Ther 20 (1998) 820-837
3. Angus D.C., Linde-Zwirble W.T., Lidicker J., et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29 (2001) 1303-1310
4. Kaplan V., Angus D.C., Griffin M.F., et al. Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med 165 (2002) 766-772
5. Fine M.J., Auble T.E., Yealy D.M., et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336 (1997) 243-250
6. Lim W.S., van der Eerden M.M., Laing R., et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58 (2003) 377-382
7. American College of Emergency Physicians. Clinical policy for the management and risk stratification of community-acquired pneumonia in adults in the emergency department. Ann Emerg Med 38 (2001) 107-113
8. Yealy D.M., Auble T.E., Stone R.A., et al. Effect of increasing the intensity of implementing pneumonia guidelines: a randomized, controlled trial. Ann Intern Med 143 (2005) 881-894
9. Angus D.C., Marrie T.J., Obrosky D.S., et al. Severe community-acquired pneumonia: use of intensive care and evaluation of the American Thoracic Society and British Thoracic Society criteria. Am J Respir Crit Care Med 166 (2002) 717-723
10. Rifai N., Gillette M.A., and Carr S.A. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol 24 (2006) 971-983
11. Christ-Crain M., and Muller B. Procalcitonin in bacterial infections-hype, hope, more or less?. Swiss Med Wkly 135 (2005) 451-460
12. Luzzani A., Polati E., Dorizzi R., et al. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med 31 (2003) 1737-1741
13. Casado-Flores J., Blanco-Quiros A., Asensio J., et al. Serum procalcitonin in children with suspected sepsis: a comparison with C-reactive protein and neutrophil count. Pediatr Crit Care Med 4 (2003) 190-195
14. Caterino J.M., Scheatzle M.D., Forbes M.L., et al. Bacteremic elder emergency department patients: procalcitonin and white count. Acad Emerg Med 11 (2004) 393-396
15. Uzzan B., Cohen R., Nicolas P., et al. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 34 (2006) 1996-2003
16. Christ-Crain M., Stolz D., Bingisser R., et al. Procalcitonin-guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 174 (2006) 84-93
17. Stolz D., Christ-Crain M., Bingisser R., et al. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest 131 (2007) 9-19
18. Christ-Crain M., Jaccard-Stolz D., Bingisser R., et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 363 (2004) 600-607
19. Tang B.M., Eslick G.D., Craig J.C., et al. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 7 (2007) 210-217
20. Jones A.E., Fiechtl J.F., Brown M.D., et al. Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Ann Emerg Med 50 (2007) 34-41
21. Masia M., Gutierrez F., Shum C., et al. Usefulness of procalcitonin levels in community-acquired pneumonia according to the Patients Outcome Research Team Pneumonia Severity Index. Chest 128 (2005) 2223-2229
22. Beovic B., Kreft S., Osredkar J., et al. Serum procalcitonin levels in patients with mild community-acquired pneumonia. Clin Microbiol Infect 11 (2005) 1050-1051
23. Nylen E., Muller B., Becker K.L., et al. The future diagnostic role of procalcitonin levels: the need for improved sensitivity. Clin Infect Dis 36 (2003) 823-824
24. Steinbach G., Rau B., Debard A.L., et al. Multicenter evaluation of a new immunoassay for procalcitonin measurement on the Kryptor System. Clin Chem Lab Med 42 (2004) 440-449
25. Aujesky D., Auble T.E., Yealy D.M., et al. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med 118 (2005) 384-392
26. Richter S.S., Beekmann S.E., Croco J.L., et al. Minimizing the workup of blood culture contaminants: implementation and evaluation of a laboratory-based algorithm. J Clin Microbiol 40 (2002) 2437-2444
27. Weinstein M.P. Blood culture contamination: persisting problems and partial progress. J Clin Microbiol 41 (2003) 2275-2278
28. Metersky M.L., Ma A., Bratzler D.W., et al. Predicting bacteremia in patients with community-acquired pneumonia. Am J Respir Crit Care Med 169 (2004) 342-347
29. Graham J.C., and Galloway A. ACP Best Practice No 167: the laboratory diagnosis of urinary tract infection. J Clin Pathol 54 (2001) 911-919
30. In: Mayhall C., Horan T.C., and Gaynes R. (Eds). Hospital Epidemiology and Infection Control (2004), Lippincott Williams & Wilkins, Philadelphia, PA 1659-1702
31. Bartlett J.G., Dowell S.F., Mandell L.A., et al. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis 31 (2000) 347-382
32. Niederman M.S., Mandell L.A., Anzueto A., et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 163 (2001) 1730-1754
33. Granato P.A. Pathogenic and indigenous microorganisms of humans. In: Murray P.R. (Ed). Manual of Clinical Microbiology (2003), American Society for Microbiology Press, Washington, DC 44-54
34. Levy M.M., Fink M.P., Marshall J.C., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions conference. Intensive Care Med 29 (2003) 530-538
35. Vincent J.L., Sakr Y., Sprung C.L., et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 34 (2006) 344-353
36. Deeks J.J., and Altman D.G. Diagnostic tests 4: likelihood ratios. BMJ 329 (2004) 168-169
37. Yealy D.M., Auble T.E., Stone R.A., et al. Effect of increasing the intensity of implementing pneumonia guidelines: a randomized, controlled trial. Ann Intern Med 143 (2005) 881-894
38. Wenzel R.P., and Fowler III A.A. Acute bronchitis. N Engl J Med 355 (2006) 2125-2130
39. Reiling J. JAMA 100 years ago: the laboratory in diagnosis. JAMA 297 (2007) 538
40. Marrie T.J., Lau C.Y., Wheeler S.L., et al., CAPITAL Study Investigators. A controlled trial of a critical pathway for the treatment of community acquired pneumonia. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA 283 (2000) 749-755
41. Macfarlane J.T., and Boldy D. 2004 Update of BTS pneumonia guidelines: what's new?. Thorax 59 (2004) 364-366
42. Mandell L.A., Wunderink R.G., Anzueto A., et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44 suppl 2 (2007) S27-S72
43. Marrie T.J., and Huang J.Q. Admission is not always necessary for patients with community-acquired pneumonia in risk classes IV and V diagnosed in the emergency room. Can Respir J 14 (2007) 212-216
44. Schelbert E. Prognostic value of B-type natriuretic peptide in unstable coronary artery disease. JAMA 295 (2006) 1895-1896